{"id":"W4282917431","doi":"10.1158/1538-7445.am2022-5271","title":"Abstract 5271: Correlative analysis of RNA biomarkers for adjuvant capecitabine benefit in the CIBOMA/2004-01phase III clinical trial of triple negative breast cancer patients","year":2022,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Oncology; Breast cancer; Internal medicine; Triple-negative breast cancer; Biomarker; Clinical endpoint; Cancer; Clinical trial; Biology; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003941826,0.0005149547,0.0009425621,0.0001789604,0.0002327124,0.0006756429,0.0004394825,0.0004997622,0.00302728],"category_scores_gemma":[0.003370793,0.0002368711,0.0006011935,0.0002534399,0.0004194609,0.0002710256,0.0001891596,0.001085851,0.0003035215],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000737235,"about_ca_system_score_gemma":0.001021957,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000575822,"about_ca_topic_score_gemma":0.001190883,"domain_scores_codex":[0.9988484,0.0008037277,0.00004430967,0.0001474664,0.00008598645,0.00007006494],"domain_scores_gemma":[0.9981616,0.0008021918,0.0004719297,0.0001862504,0.0001152371,0.0002628652],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8774141,0.003992707,0.05617226,0.0005199101,0.001679611,0.00006124933,0.00009303955,0.0009483167,0.01946633,0.0002577579,0.00200923,0.03738547],"study_design_scores_gemma":[0.4107485,0.2608865,0.2860255,0.0001134136,0.004633145,0.0003418879,0.0001094913,0.005374579,0.02266842,0.0007672675,0.008268203,0.00006320125],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9953635,0.00132626,0.0003718349,0.0003011662,0.00006128794,0.0006712682,0.0007580327,0.00001808299,0.001128572],"genre_scores_gemma":[0.9948925,0.0002750005,0.0009558388,0.0002951929,0.00007947783,0.001003911,0.001208684,0.000008665195,0.001280725],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003941826,"threshold_uncertainty_score":0.02084661,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0631960871830504,"score_gpt":0.4173593357242745,"score_spread":0.3541632485412241,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}